Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedinexSGX:OTX 58 Net Margin % is 2.01% as of Mar. 2026, which is 91% below its 10-year median of 22.77. GuruFocus rates SGX:OTX with a GF Score™ of 58/100 and a GF Value™ of S$0.20 (Fairly Valued). The stock has 7 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Medinex ranks better than 92.15% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Medinex's Net Income for the
six
months ended in Mar. 2026 was S$0.13 Mil. Medinex's Revenue for the
six
months ended in Mar. 2026 was S$6.37 Mil. Therefore, Medinex's net margin for the quarter that ended in Mar. 2026 was 2.01%.
The historical rank and industry rank for Medinex's Net Margin % or its related term are showing as below:
SGX:OTX'
s Net Margin % Range Over the Past 10 Years
Min: 8.21 Med: 22.77 Max: 42.28
Current: 17.92
SGX:OTX's Net Margin % is ranked better than 92.15% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 2.965
vs SGX:OTX: 17.92
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Medinex Net Margin % Related Terms
Medinex Net Margin % Historical Data
* Premium members only.
The historical data trend for Medinex's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medinex's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinex Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medinex's Net Margin % distribution charts can be found below:
* The bar in red indicates where Medinex's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinex (SGX:OTX) has a Net Margin % of 2.01% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Medinex and its competitors. This is 91% below median its historical median of 22.77. Over the past decade, Medinex's Net Margin % has ranged from 8.21 to 42.28. According to the industry distribution chart, Medinex ranks #52 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 7.9%.
Is Medinex's Net Margin % too high?
Medinex's current Net Margin % of 2.01% is 91% below median its 10-year median of 22.77. Over the past 10 years, this metric has ranged from a low of 8.21 to a high of 42.28. The Healthcare Providers & Services industry median Net Margin % is 2.97. Medinex's value of 2.01% is 32.2% below this industry median. Based on the distribution chart, Medinex ranks #52 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medinex has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medinex's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medinex ranks #52 out of 662 companies for Net Margin %. This places Medinex in the top 8% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.97. Medinex's value of 2.01% is 32.2% below this benchmark. Historically, Medinex's own Net Margin % has ranged from 8.21 to 42.28 over the past decade. While the company's 10-year median is 22.77 vs. the industry median of 2.97, Medinex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.97, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinex's current Net Margin % of 2.01% is 32.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medinex and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinex's current Net Margin % is 2.01%, which is 91% below median its own 10-year median of 22.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinex stock overvalued right now?
Based on GuruFocus' analysis, Medinex (SGX:OTX) is currently considered Fairly Valued. The stock's GF Value™ is S$0.20, compared to a current price of S$0.22 — trading 10% above its estimated fair value. The current Net Margin % is 2.01%, which is 91% below median its 10-year median of 22.77 and 32.2% below the Healthcare Providers & Services industry median of 2.97. Medinex's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medinex (SGX:OTX), the current Net Margin % is 2.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinex (SGX:OTX) Overvalued in 2026?
Based on GuruFocus' analysis, Medinex stock appears to be overvalued.
The current stock price of S$0.22 is trading 10% above its estimated GF Value™ of S$0.20.
GuruFocus considers Medinex to be Fairly Valued.
Key valuation signals for SGX:OTX:
Net Margin %: 2.01% (91% below median its 10-year median of 22.77)
GF Value™: S$0.20 vs. price of S$0.22 (10% above fair value)
Industry Position: 32.2% below the Healthcare Providers & Services median (#52 of 662)
No single metric tells the full story. See the SGX:OTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinex Ltd is an investment holding company. The company has four business segments: Medical Support Services, Business Support Services, Pharmaceutical Services, and Medical Services. The company generates maximum revenue from the Business Support Services segment. The Business support services business segment provides professional services to customer base who are outside from healthcare industry.
58GF Score
Get the complete analysis for SGX:OTX
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:OTX has been successfully added to your 
